Trichloroethylene toxicity by Yu, Dianyi & United States, Agency for Toxic Substances and Disease Registry., Division of Toxicology and Environmental Medicine.
Agency for Toxic Substances and Disease Registry 
Case Studies in Environmental Medicine (CSEM) 
Trichloroethylene Toxicity 
 
Course: WB1112  
Original Date: November 8, 2007 
CE Expiration Date: November 8, 2010 
Table of Contents 
How to Use This Course ............................................................................................ 3 
Initial Check............................................................................................................ 5 
What is Trichloroethylene? ...................................................................................... 10 
Where is Trichloroethylene Found? ........................................................................... 12 
How Are People Exposed to Trichloroethylene? ........................................................... 15 
Who Is at Risk of Trichloroethylene Exposure? ........................................................... 16 
What Are the U.S. Standards for Trichloroethylene Exposure? ...................................... 18 
What Is the Biological Fate of Trichloroethylene in the Body?........................................ 21 
What Are the Physiological Effects of Trichloroethylene? .............................................. 25 
How Should Patients Exposed to Trichloroethylene Be Evaluated? ................................. 32 
What Laboratory Tests Can Assist in the Evaluation of Patients Exposed to 
Trichloroethylene?.................................................................................................. 37 
How Should Patients Exposed to Trichloroethylene Be Treated and Managed? ................. 40 
What Instructions Should Be Given to Patients?.......................................................... 42 
Where Can I Find More Information?......................................................................... 44 
Posttest................................................................................................................ 45 
Literature Cited ..................................................................................................... 49 
Answers to Progress Check Questions ....................................................................... 56 
 
Key Concepts • Trichloroethylene (TCE) is a common industrial solvent and 
contaminant of hazardous waste sites, groundwater, and drinking 
water. 
• TCE is a CNS depressant and a suspected hepatotoxin in humans. 
• TCE is reasonably anticipated to be a human carcinogen based on 
limited evidence of carcinogenicity from studies in humans and 
sufficient evidence of carcinogenicity from studies in experimental 
animals. 





This educational case study document is one in a series of self-
instructional publications designed to increase the primary care 
provider’s knowledge of hazardous substances in the environment and 
to promote the adoption of medical practices that aid in the evaluation 
and care of potentially exposed patients. The complete series of Case 
Studies in Environmental Medicine is located on the ATSDR Web site at 
www.atsdr.cdc.gov/csem/. In addition, the downloadable PDF version 
of this educational series and other environmental medicine materials 
provides content in an electronic, printable format, especially for those 
who may lack adequate Internet service. 




See Internet address www2.cdc.gov/atsdrce/ for more information 
about continuing medical education credits, continuing nursing 
education credits, and other continuing education units. 
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How to Use This Course 
Introduction The goal of Case Studies in Environmental Medicine (CSEM) is to 
increase the primary care provider’s knowledge of hazardous 
substances in the environment and to aid in the evaluation of 




Two versions of the Trichloroethylene Toxicity CSEM are available: 
• the HTML version http://www.atsdr.cdc.gov/csem/tce/ provides 
content through the Internet; 
• the downloadable PDF version provides content in an electronic, 
printable format, especially for those who may lack adequate 
Internet service. 
The HTML version offers interactive exercises and prescriptive feedback 
to the user. 
Instructions To make the most effective use of this course, we recommend that 
you: 
• take the initial check to assess your current knowledge about 
trichloroethylene toxicity, 
• read the title, learning objectives, text, and key points in each 
section, 
• complete the progress check exercises at the end of each section 
and check your answers, and 
• complete and submit your assessment and posttest responses 
online if you wish to obtain continuing education credit. 




This course is designed to help you learn efficiently. Topics are clearly 
labeled so that you can skip sections or quickly scan sections you are 
already familiar with. This labeling will also allow you to use this 
training material as a handy reference. To help you identify and absorb 
important content quickly, each section is structured as follows 
 
Section Element Purpose 
Title Serves as a “focus question” that you should be able to answer after 
completing the section 
Learning Objectives Describes specific content addressed in each section and focuses your 
attention on important points  
Text Provides the information you need to answer the focus question(s) 
and achieve the learning objectives 
Key Points Highlights important issues and helps you review 
Progress Check 
exercises 
Enables you to test yourself to determine whether you have mastered 
the learning objectives 
Progress Check 
answers 
Provides feedback to ensure you understand the content and can 
locate information in the text 
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Upon completion of the Trichloroethylene Toxicity CSEM, you should be 
able to: 
• explain what trichloroethylene (TCE) is, 
• identify sources of trichloroethylene exposure, 
• identify the primary route of exposure to trichloroethylene, 
• identify the populations most heavily exposed to trichloroethylene, 
• identify who is at risk of exposure to trichloroethylene, 
• identify the OSHA permissible exposure limit (PEL) for 
trichloroethylene, 
• identify EPA’s maximum contaminant level (MCL) for trichloroethylene 
in drinking water, 
• explain the characteristics of the absorption, distribution, metabolism 
and elimination of TCE in the body, 
• describe the physiological effects associated with trichloroethylene 
exposure, 
• identify the primary focuses of the exposure history, 
• describe the characteristic finding on patient examination, 
• describe characteristic clinical presentations of patients with acute or 
chronic trichloroethylene exposure, 
• identify direct and indirect measurements that can assist with 
diagnosis of trichloroethylene exposure, 
• describe the principal treatment strategy for managing 
trichloroethylene poisoning, 
• describe advice on self care and follow-up care normally provided to 
patients exposed to trichloroethylene. 
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Initial Check 
Instructions This Initial Check will help you assess your current knowledge about 
trichloroethylene toxicity. To take the Initial Check, read the case below 
and then answer the questions that follow. 
Case Study Concerns of a young family exposed to TCE-contaminated 
drinking water 
Your practice is in a suburban community with a number of high-
technology industries. A couple for whom you have been the family 
physician asks for an appointment to discuss their daughter's illnesses 
and a matter of concern to them. 
During the initial consultation, the mother reports that they are living in 
an area supplied by municipal well water. They have recently received a 
notice from the municipal water district stating that their drinking water 
contains 100 parts per billion (ppb) trichloroethylene (TCE), and as a 
precaution, they are being supplied with bottled drinking water until an 
alternative well can be put into service. The notice indicates that the well 
water is suitable for bathing and laundering. The father interjects that he 
is familiar with TCE; it is used in the electronics plant where he works. 
The daughter, aged four has had a number of ear infections during her 
first two years, culminating in a myringotomy at age three. Follow-up by 
an Ear, Nose, and Throat (ENT) specialist has shown normal hearing. 
Although there have been no further infections, the mother stresses that 
her daughter seems to have a greater number of colds than her 
classmates and "has not seemed as healthy as she should be." However, 
the daughter's chart does not reflect an unusual number of office visits or 
calls. The mother also notes that the child's day-care center is next to 
"some kind of machine shop" where a chemical odor has been noticed 
recently. Several of the children and one of the teachers have 
complained of eye and throat irritation in association with the odor. 
The mother, who is 33 years old, then reveals that she might be 
pregnant and she has had mild nausea for one week. It has been eight 
weeks since her last menstrual period. Both parents are concerned about 
the possibility that the TCE in the drinking water might have affected the 
fetus. Although this pregnancy was planned, they might consider 
terminating the pregnancy if the fetus was likely to be "damaged." They 
are also concerned that the entire family might suffer from cancer or 
other diseases in the future. 
Before receiving bottled water, the family drank tap water when thirsty 
and made coffee with tap water. Tap water also was used for cooking 
and brushing teeth, and is still used for bathing. They have never noticed 
discoloration or an off-taste to the tap water. They encourage their child 
to drink water instead of sodas during the summer and estimate the 
amount of water each of them drinks is two to three glasses a day. 
You schedule each parent and the child for an individual office visit. 
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1. What would you include in the mother's and daughter's problem list? 
2. What additional information would you seek before seeing the family 
again? 
3. What reassurances might you provide at the end of this initial visit? 
4. What are the possible sources of exposure to TCE for the family 
described in the case study? 
5. Which members of the family described in the case study are at 
increased risk for adverse effects from TCE? Explain. 
6. On the next visit to your office, the mother states that some families 
in their neighborhood are being seen by another practitioner, who has 
sent specimens to a laboratory for measurement of indicators of TCE 
exposure. What biologic indicators of TCE exposure are likely being 
measured? 
7. If biologic measurements are performed, what considerations should 
be taken into account to properly interpret the results? 
8. The father says that he has felt increasingly tired and easily fatigued 
for the past few months. Results of his physical examination are 
entirely within normal limits. What tests, if any, would you order? 
9. The mother's obstetrician calls one month later. Examination, 
including sonogram, is normal for her stage of pregnancy. The 
obstetrician asks you about the potential fetotoxicity of TCE and 
whether a more invasive evaluation (amniocentesis or chorionic villus 
biopsy) is indicated. What is your response? 
10. You evaluate the 4-year-old child. A review of her history reveals 
three to four episodes of otitis media, which were treated with 
ampicillin, in each of the last three years. The child was placed on 
continuous prophylactic antibiotics during the last two cold seasons. 
Last year, the child developed additional infections despite the 
antibiotic regimen, and you referred her to an otolaryngologist, who 
performed a myringotomy and tympanostomy without incident. The 
mother estimates the child has had four episodes of coryza or mild 
influenza last year, with about seven days of illness that merited 
staying home from day care. 
 Does this pattern reflect compromise of the child's immune system? 
11. The mother asks about immune system tests. A health care 
practitioner evaluating other families has performed such tests. Is the 
assessment of immunocompetence appropriate in this case? 
12. TCE has been identified as the irritant at the day-care center. The 
mother described in the case study is concerned and wishes to take 
action to get the level reduced. What can you recommend to her? 
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1. The mother's problem list includes pregnancy and anxiety; the child's, 
frequent otitis media (status post myringotomy and tympanostomy 
tube placement) and frequent upper respiratory infections. 
 
2. You will need information on TCE toxicity, including reproductive and 
developmental effects; information on TCE contamination of the 
family's drinking water, including duration and level of contamination; 
copies of information provided to the family by the municipal water 
company; and responses, if any, from local and state health agencies. 
More information for this answer can be found in the sections “How Are 
People Exposed to Trichloroethylene?” and “What Are the Physiologic 
Effects of Trichloroethylene?” 
3. None of the symptoms described in the case indicate serious illness. 
However, you should reassure the family that you will perform a 
complete physical examination with appropriate testing at the next 
visit. In response to concern about the child's infections, you should 
indicate that you will collect information about possible TCE effects on 
the immune system. Explain to the parents that tests of immune 
function are often difficult to interpret and might not be appropriate. 
You might indicate that you will consult sources of information on TCE's 
effects on pregnancy. It is important to maintain a balance between 
reassurance that the unborn child is probably not affected by the water 
contamination and concern for the possible risk to the fetus. 
Reassurance should not, however, appear to trivialize the family's 
fears. It would also be appropriate to discuss that no evaluation, 
however thorough, can totally exclude the possibility that a person 
might develop an illness, including cancer. 
More information for this answer can be found in the section “What Are 
the Physiologic Effects of Trichloroethylene?” 
4. Possible sources of the family's TCE exposure include home drinking 
water (ingestion and dermal and inhalation exposure during bathing), 
the father's workplace (inhalation), and the daughter's day-care center 
(inhalation). Other sources would be washing dishes, laundry, or any 
other use of hot water in the home; the use of TCE-containing 
consumer products such as correction fluid, spot removers, and so 
forth. 
More information for this answer can be found in the section “How Are 
People Exposed to Trichloroethylene?” 
5. All members of the family described in the case study are at increased 
risk for adverse effects from TCE exposure.  
More information for this answer can be found in the section “How Are 
People Exposed to Trichloroethylene?” 
Page 7 of 57 
Agency for Toxic Substances and Disease Registry Trichloroethylene Toxicity 
Case Studies in Environmental Medicine (CSEM) 
 
6. The most convenient biologic indicators of TCE exposure are the 
urinary metabolites, trichloroethanol and trichloroacetic acid. These 
metabolites are not specific to TCE, however, because they are also 
metabolites of tetrachloroethylene (perchloroethylene), 1,1,1-
trichloroethane (methyl chloroform), and certain medications. TCE 
itself can be measured directly in blood or exhaled air, but because of 
the difficulty of obtaining samples, such measurements are not 
indicated here. 
More information for this answer can be found in the section “What 
Laboratory Tests Can Assist in the Evaluation of Patients Exposed to 
Trichloroethylene?” 
7. To properly interpret any of the tests mentioned in answer 6, 
knowledge of the time lapse between exposure and collection is 
necessary. To prevent contamination or sample loss (evaporation or 
adsorption), the proper collection, handling, storage, and 
transportation procedures must be followed. It is likely that members 
of this family would have elevated levels of TCE or its metabolites, 
above background levels, for a few hours after exposure, for instance, 
after they shower. However, there are no appropriate reference values 
currently available for a health risk assessment. 
More information for this answer can be found in the section “What 
Laboratory Tests Can Assist in the Evaluation of Patients Exposed to 
Trichloroethylene?” 
8. No further studies are indicated for TCE exposure. A workup for fatigue 
can indicate additional tests. 
 
9. Evidence from animal and epidemiologic studies suggests that several 
reproductive and developmental toxicity end points may be associated 
with TCE exposure, including infertility in males and females, impaired 
fetal growth, and cardiac teratogenesis. Invasive procedures are 
therefore justified in this case. 
More information for this answer can be found in the section “What Are 
the Physiologic Effects of Trichloroethylene?” 
10. No. A survey of infections in children under three years of age over a 
September-to-March period found an average of 2.5 total infections 
and more than one episode of otitis media per child (1.4 episodes per 
child for those in day care). More than 3% of the children in day care 
were hospitalized for tympanostomies (Bell, Gleiber et al. 1989). The 
child described in the case study appears to have an above-average 
rate of infections, but they are not frequent enough to suggest 
immunologic impairment. 
 
11. No. Immunocompetence tests are not appropriate because no evidence 
of immune function abnormalities has been found in this case. It is 
uncertain about TCE drinking water exposures and immune system 
abnormalities given the lack of quality studies on this question. 
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Primary immunodeficiency is suspected in an infant who has repeated 
upper respiratory tract or other infections. It is also suspected if 
repeated infection occurs in a child who has had little exposure to 
infectious agents, or any child with unusual infections, incomplete 
clearing of infections, growth failure, hepatosplenomegaly, or features 
associated with specific immunodeficiency disorders, such as ataxia or 
telangiectasia. The child described in the case study has none of these 
indications. 
More information for this answer can be found in the section “What Are 
the Physiologic Effects of Trichloroethylene?” 
12. Although EPA has not issued an emission standard for TCE, New York 
State has set a guideline for TCE air emission of 5 µg/m³.  
Assuming discussions with the owner or operator of the shop adjacent 
to the day-care center have not been effective in reducing the level of 
ambient TCE, the community's air pollution control center should be 
notified. States might allow this control under the jurisdiction of local 
air pollution control districts, county health departments, or other local 
agencies. The agency responsible for enforcement of air standards 
should be contacted to investigate possible release of TCE onto the 
day-care center property. 
More information for this answer can be found in the section “What Are 
the U.S. Standards for Trichloroethylene Exposure?” 
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What is Trichloroethylene? 
Learning 
Objectives 
Upon completion of this section, you should be able to: 
• explain what TCE is. 
Definition TCE (Cl2C=CHCl) is a clear, colorless, nonflammable liquid possessing a 
sweet, fruity odor characteristic of chloroform. The odor threshold is 
approximately 100 parts per million (ppm) (Agency for Toxic Substances 
and Disease Registry 1997). 
Uses  Estimated use patterns suggest that 80% of TCE is used for vapor 
degreasing of fabricated metal parts in the automotive and metal 
industries.  
Consumer products that contain TCE include: 
• adhesives, 
• spot removers, 
• cleaning fluids for rugs, 
• paint removers/strippers, and 
• typewriter correction fluids 
Other Uses Before its ban for certain applications in 1977, TCE was also used as a 
general (mostly obstetric) anesthetic, grain fumigant, disinfectant, pet 
food additive, and extractant of spices in foods and caffeine in coffee 
(Candura and Faustman 1991) 
Synonyms Trichloroethylene is also known as 
• acetylene trichloride, 
• ethylene trichloride, 
• TCE, 
• Tri, and 
• trichloroethene 
Trade names for trichloroethylene include: 
• Benzinol, 
• Circosolve, 
• Flock Fli, 
• Narcogen, 
• Perm-A-Chlor, 
• Tri-clene, and  
• Vestrol 
Key Points • TCE is used mainly for vapor degreasing of fabricated metal parts in 
the automotive and metal industries. 
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1. Trichloroethylene is: 
A. a clear, colorless, nonflammable liquid 
B. used for vapor degreasing of fabricated metal parts in the 
automotive and metal industries 
C. no longer used as a general anesthetic, grain fumigant, 
disinfectant, or pet food additive since 1977 
D. all of the above. 
To review relevant content, see “Definition,” “Uses,” and “Other 
Uses” in this section. 
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Where is Trichloroethylene Found?  
Learning 
Objectives 
Upon completion of this section, you should be able to: 
• identify sources of TCE exposure. 
Introduction TCE does not occur naturally; therefore, its presence indicates 
manufacture, use, or storage. Production of TCE has increased from just 
over 260,000 lbs in 1981 to 320 million lbs in 1991. The U.S. 
International Trade Commission (USITC) has not published more recent 
production statistics because there are only two U.S. manufacturers 
(Agency for Toxic Substances and Disease Registry 1997; HSDB April 
2006). 
Vapor degreasing of fabricated metal parts and some textiles accounts 
for 80% of its use. 5% is used as an intermediate in the production of 
organic chemicals and pharmaceuticals. Miscellaneous uses (5%) 
include solvents for dry cleaning, extraction and as a refrigerant/heat 
exchange liquid. An estimated 10% is exported. 
Occupational 
Exposures 
Occupational exposures may occur in chemical industries that 
manufacture: 
• other polychlorinated aliphatic hydrocarbons, flame retardant 
chemicals, and insecticides where TCE is a chemical intermediate, 
• pentachloroethane, or 
• polyvinyl chloride. 




• pharmaceuticals, and 
• soaps. 
The following occupations also have increased likelihood of exposure: 
• dry cleaners, 
• mechanics, 
• oil processors, 
• printers, 
• resin workers, 
• rubber cementers, 
• shoemakers, 
• textile and fabric cleaners, 
• varnish workers, and 
• workers reducing nicotine in tobacco. 
Although some dry cleaners used TCE in the past, most dry cleaners 
now use tetrachloroethylene (perchloroethylene) or 1,1,1-
trichloroethane. 
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In the workplace, TCE is seldom present as a pure substance. Industrial 
grade TCE contains small amounts of stabilizers in the form of 
antioxidants or acid receptors; total chemical impurities usually do not 
exceed 0.1% by weight. Decomposition of TCE into dichloroacetylene (a 
neurotoxic compound) and phosgene (a serious pulmonary irritant) 
occurs in the presence of alkali at temperatures above 60°C for the 
unstabilized compound and above 130°C for the stabilized compound. 
Environmental 
Exposures 
Because of its widespread use, TCE has become a common 
environmental contaminant. Contamination results from: 
• discharge to surface waters and groundwater by industry commerce, 
and individual consumers, 
• evaporative losses during use, 
• incidental addition of TCE during food production, or 
• leaching from hazardous waste landfills leaching into groundwater 
In the atmosphere, TCE is destroyed by photooxidation, with a half-life 
of 3-8 days during the summer months and approximately 2 weeks in 
cold climates during the winter. This relatively short half-life significantly 
limits the transport of TCE in air; however, the continual volatilization of 
TCE from emission sources or contaminated surface waters ensures its 
persistence in air.  
The average TCE level detected in samples collected from ambient air in 
the Norwegian Arctic between 1982 and 1983 was 0.007 ppb. This 
compares to mean TCE concentrations of 0.03 ppb in rural or remote 
areas, 0.46 ppb in urban and suburban areas, and up to 1.2 ppb in 
areas near emission sources of TCE. Indoor air concentrations have 
ranged from 0.14 ppb in a school to 5 ppb in an office building (Agency 
for Toxic Substances and Disease Registry 1997). 
TCE is now a common contaminant at Superfund sites and many 
Department of Defense facilities. TCE has been identified in at least 861 
of the 1,428 sites proposed for inclusion on the U.S. EPA National 
Priorities List (Agency for Toxic Substances and Disease Registry 1997). 
According to U.S. EPA Toxic Release Inventory (Wu and Schaum 2000; 
U.S. EPA 2003). TCE releases into the environment have ranged from 
55.6 million pounds in 1987 down to 7.2 million pounds in 2003. 
TCE in drinking water is a result of its rapid leaching from landfills and 
its discharge from industrial wastewaters. TCE volatilizes quickly from 
water at a rate that depends on temperature, water movement, and 
aeration. The biodegradation of TCE under anaerobic conditions is slow, 
making TCE relatively persistent in subsurface waters. An EPA national 
groundwater survey (US Environmental Protection Agency 1985) 
detected TCE in approximately 10% of the wells tested. It is the most 
frequently detected organic solvent in groundwater supplies, and is 
estimated to be in up to 34% of the nation's drinking water supplies 
(Agency for Toxic Substances and Disease Registry 1997). 
Because of TCE's volatility, household activities such as bathing, 
laundering, and cooking with contaminated water may produce TCE air 
concentrations above ambient levels.  
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Both natural and processed foods may contain TCE because of direct 
uptake through the environment, contamination of water used in food 
processing, and contamination by solvents used in cleaning food 
processing equipment. Most processed foods examined contain levels of 
a few parts per billion. Studies indicate that TCE has a low tendency to 
bioaccumulate in the food chain (Agency for Toxic Substances and 





TCE is found as an ingredient in a number of consumer products such as 
• adhesives, 
• cleaning fluids for rugs, 
• paint removers/strippers, 
• spot removers, spot removers, and  
• typewriter correction fluids. 
Key Points • Workplace is a major source of TCE exposure. 
• The most common sources of non-occupational exposure to TCE are 
ambient air and drinking water. 
Progress 
Check 
2. TCE is a common environmental contaminant. What sources does 
contamination result from? 
A. evaporative losses during use 
B. discharge to surface waters and groundwater by industry, 
commerce, and individual consumers 
C. leaching from hazardous waste landfills into groundwater 
D. all of the above. 
To review relevant content, see “Environmental Exposures” in this 
section. 
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How Are People Exposed to Trichloroethylene? 
Learning 
Objectives 
Upon completion of this section, you should be able to 
• identify the primary route of exposure to TCE. 
Introduction Occupational exposure to trichloroethylene may occur through inhalation 
and dermal contact at workplaces where TCE is produced or used.  
The general population may be exposed to TCE via inhalation of ambient 
air and ingestion of food and drinking water. 
 
Inhalation  The air pathway is the most common route of exposure to TCE, and the 
route that most commonly leads to illness. Exposure scenarios include 
inhalation of contaminated air: 
• because of vapors formed during bathing and laundering from using 
contaminated water at home, 
• due to accidental spills, and use of products in small, enclosed 
spaces, 
• due to deliberate abuse because TCE inhalation can cause euphoria, 
• during work in the same space as others working with TCE, 
• during work with TCE, 
• in areas where TCE is released to air and water by evaporation or 
fugitive emissions from industrial and from landfills, and 
• on worker’s skin and clothing. 
Ingestion Ingestion—a minor pathway of exposure—occurs through 
• incidental addition of TCE during food production and 
• swallowing food or drinking water contaminated with TCE 
Skin  Dermal contact is a common route of TCE exposure in workplace and 
among the general public. However, dermal contact is less important 
since it is not likely to cause toxic effects under normal conditions.  
Key Points • The main route of occupational exposure to TCE is by inhalation. 
Progress 
Check 
3. The primary route of exposure to trichloroethylene is: 
A. ingestion 
B. inhalation 
C. dermal contact 
D. all are equally important 
To review relevant content, see “Inhalation” in this section. 
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Who Is at Risk of Trichloroethylene Exposure? 
Learning 
Objective 
Upon completion of this section, you should be able to: 
• identify the populations most heavily exposed to TCE and 
• identify who is at risk of exposure to TCE. 
Introduction Most significant exposures to TCE occur in the workplace. Occupational 
exposure to TCE in the U.S. has been identified in various degreasing 
operations, silk screening, taxidermy, and electronic cleaning.  
Worker 
Exposure 
The National Institute for Occupational Safety and Health (NIOSH) 
conducted a survey of various industries from 1981 to 1983 and 
estimated that approximately 401,000 U.S. employees in 23,225 plants 
are potentially exposed to TCE. Time-weighted average concentrations 
from personal monitoring ranged from 1.2 to 5.1 ppm at individual 
industrial sites where TCE was used (Agency for Toxic Substances and 
Disease Registry 1997; Wu and Schaum 2000). 
Deaths have occurred in workers who were accidentally exposed to high 
levels (up to 8,000 ppm) of TCE, and in solvent abusers deliberately 
sniffing typewriter correction fluid (King, Smialek et al. 1985). Some of 
these deaths were due to asphyxia, whereas others were attributed to 
either ventricular fibrillation or asystole.  
Although no human studies have directly assessed potential 
dysrhythmogenic effects of TCE, no evidence exists to show that persons 
exposed to TCE at background environmental concentrations or at 
allowable workplace levels are at increased risk of developing cardiac 
dysrhythmias (Candura and Faustman 1991). 
Increased potential for exposure may be encountered by the following 
workers: 
• dry cleaners, 
• mechanics, 
• oil processors, 
• printers, 
• resin workers, 
• rubber cementers, 
• shoe makers, 
• textile and fabric cleaners, 
• tobacco denicotinizers, and  
• varnish workers 
TCE Inhalant 
Abuse 
Inhalants - particularly volatile solvents, gases, and aerosols - are often 
among the first drugs that young children use. One national survey 
indicates that about 3.0 percent of U.S. children have tried inhalants by 
the time they reach fourth grade. About 17% of US youth has ever tried 
to get ‘high’ from inhaled solvents, including TCE. National surveys 
indicate that more than 22.9 million Americans have abused inhalants at 
least once in their lives (NIDA 2005). Inhalant abuse can become chronic 
and extend into adulthood. Sudden death due to TCE abuse has been 
reported (Miller, Mycyk et al. 2002). 
Page 16 of 57 
Agency for Toxic Substances and Disease Registry Trichloroethylene Toxicity 
Case Studies in Environmental Medicine (CSEM) 
 
Banned Uses Until 1977, when certain uses were banned, TCE was employed as an 
inexpensive, nonflammable, and self-administered obstetrical anesthetic 
(Tri-lene). It was discovered that alkali in rebreathing systems could lead 
to the production of dichloroacetylene, which produces cranial nerve 
injuries. Workers in environments containing this TCE-decomposition 
product could also be at risk of developing injury to trigeminal, optic, or 
facial nerve (Lawrence and Partyka 1981). 
Degreaser’s 
Flush 
Alcohol potentiates TCE's effects on the central nervous system (CNS). 
Concurrent alcohol consumption and exposure to TCE can result in 
"degreaser's flush," (Stewart, Hake et al. 1974) a temporary redness and 
itching of the back, neck, and face. Liver dysfunction or disulfiram 
(Antabuse) treatment could reduce the metabolism of TCE thereby 
increasing its CNS depressant effects. 
Use of 
Groundwater 
TCE is one of the volatile organic contaminants most frequently found in 
groundwater. There have been a number of studies reported that 
examined the health of persons who ingested TCE-contaminated 
groundwater over varying period of time. The results of these studies 
have been inconsistent. A link between ingestion of TCE and incidence of 
cancer in humans is controversial, but has not been excluded.  
Maternal 
Transmission 
TCE rapidly crosses the placenta in both humans and animals, and can 
accumulate in the fetus (Agency for Toxic Substances and Disease 
Registry 1997). To gather information on the health effects of ingesting 
TCE-contaminated water, the ATSDR, in cooperation with the states, has 
established a national registry. This registry is discussed in Sources of 
Information section. 
Key Points • Workers in metal-fabricating and cleaning operations have the 
greatest likelihood of exposure to high concentrations of TCE. 
• Persons using groundwater contaminated with trichloroethylene can 
be exposed by inhalation as well as ingestion. 
• Trichloroethylene crosses the placenta and can accumulate in the 
fetus. 
• Ingestion of alcohol may potentiate the central nervous system 
depressant effects of TCE. 
Progress 
Check 
4. Occupations that entail exposure to trichloroethylene include which of 
the following? 
A. workers in metal-fabricating and cleaning operations 
B. workers in dry cleaners 
C. shoemakers 
D. all of the above. 
To review relevant content, see “Worker Exposure” in this section. 
5. Who is most likely to be at risk of trichloroethylene exposure? 
A. the newborns of nursing mothers who are employed at a chemical 
industry. 
B. residents who use well water for food preparation, bathing, and 
laundry. 
C. consumers who use spot remover. 
D. mechanics who degrease fabricated metal parts in the automotive 
industries. 
To review relevant content, see “Worker Exposure” in this section. 
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What Are the U.S. Standards for Trichloroethylene Exposure? 
Learning 
Objectives 
Upon completion of this section, you should be able to: 
• identify the OSHA permissible exposure limit (PEL) for TCE and 
• identify the EPA’s maximum contaminant level (MCL) for TCE in 
drinking water. 
Introduction The government has developed regulations and guidelines for TCE. 
These standards are designed to protect the public from potential 
adverse health effects. 
Workplace 
Standards 
The OSHA permissible exposure limit (PEL) is a time-weighted average 
(TWA) of 100 ppm, with 300 ppm TCE as a 5-minute maximum peak 
allowable in any 2-hour period (OSHA 1993). 
The National Institute for Occupational Safety and Health (NIOSH) 
considers TCE a potential occupational carcinogen and recommends an 
exposure limit of 2 ppm (as a 60-minute ceiling) during the usage of 
TCE as an anesthetic agent (TCE is no longer used as an anesthetic 
agent) and 25 ppm as a 10-hour TWA during all other exposures.  
The American Conference of Governmental Industrial Hygienists 
(ACGIH) recommends an 8-hour TWA of 50 ppm and a short-term 
exposure limit (STEL) of 100 ppm (American Conference of 
Governmental Industrial Hygienists. 2003). 
Biologic exposure indices (BEIs) recommended by ACGIH that might 
involve either direct or indirect measures of individual worker exposure. 
• The TCE metabolite, free trichloroethanol, can be measured in the 
blood. However, a number of other compounds affect the level of 
trichloroethanol found in the blood, thereby clouding the clinical 
significance of this metabolite as an indicator of TCE exposure. Thus, 
if higher-than-expected blood levels of trichloroethanol are detected, 
the clinician must consider alternate explanations for the elevated 
levels (Agency for Toxic Substances and Disease Registry 1997). 
• Alternatively, a concentration of 100 milligrams (mg) of 
trichloroacetic acid per gram of creatinine in urine at the end of the 
work week reflects the upper biologic limit for TCE exposure. Urinary 
trichloroacetic acid levels can be increased by the same compounds 
that affect blood trichloroethanol levels (Agency for Toxic Substances 
and Disease Registry 1997). Because of large individual variations, a 
urinary trichloroacetic acid level of 100 mg per gram of creatinine 
should be used only as a "warning" level or mean for a group of 
workers (American Conference of Governmental Industrial 
Hygienists. 2003; Meditext 2004). 
Table 1 summarizes current standards and regulations for TCE 
exposure. 
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Table 1. Standards and Regulations for Trichloroethylene. 








50 ppm  
100 ppm 

















100 ppm  
300 ppm  
Regulation; PEL¶ over 8-hour workday  










5 ppb  Regulation 
* ppm: parts per million; ppb: parts per billion. 
†TLV/TWA (threshold limit value/time-weighted average): time-weighted average 
concentration for a normal 8-hour workday or 40-hour work week to which nearly all 
workers may be repeatedly exposed.  
‡STEL(short-term exposure limit): concentration at which workers can be exposed 
continuously for a short period of time (usually 15 minutes) without suffering irritation, 
chronic irreversible tissue damage, or narcosis.  
§TWA (time-weighted average): concentration for a normal 8-hour workday and 40-hour 
work week is set at a level at which nearly all workers may be repeatedly exposed without 
adverse effects.  
¶PEL (permissible exposure limit): highest level averaged over an 8-hour workday to which 
a worker may be exposed. Note: A PEL of 50 ppm was enacted by Occupational Safety and 
Health Administration in 1989, but that level along with 375 others, was vacated for 
procedural reasons by the 11th Circuit Federal Court in 1993. 
 
 
Page 19 of 57 
Agency for Toxic Substances and Disease Registry Trichloroethylene Toxicity 






Environmental exposures to TCE are generally low and are decreasing 
because limitations have been imposed on its use as an anesthetic, 
solvent extractant, fumigant, and dry-cleaning agent. 
Air 
TCE has a short atmospheric half-life (less than seven days) and is not 
likely to bioaccumulate in the food chain. 
Water 
The World Health Organization recommended drinking water limit is 30µg 
TCE/liter (L) of water (30 ppb). EPA has set a maximum contaminant 
level (MCL) of 5µg/L (5 ppb) in drinking water (US Environmental 
Protection Agency 1985). 
Although there is no incontrovertible evidence of human health effects 
associated with exposures to environmental levels of TCE (Brown, Farrar 
et al. 1990), the issue is not entirely settled. More reliable information is 
necessary for a final assessment. 
Key Points • OSHA’s current permissible exposure limit is 100 ppm. 
• EPA has established a drinking water MCL for TCE of 5 ppb. 
Progress 
Check 
6. OSHA’s PEL for TCE in the workplace is which of the following? 
A. 50 ppm (8-hour TWA) 
B. 100 ppm (8-hour TWA) 
C. 25 ppm (8-hour TWA) 
D. none of the above. 
To review relevant content, see “Table 1” in this section. 
7. EPA’s MCL for TCE in drinking water is which of the following? 
A. 5 ppm 
B. 5 ppb 
C. 10 ppb 
D. none of the above. 
To review relevant content, see “Table 1” in this section. 
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What Is the Biological Fate of Trichloroethylene in the Body?  
Learning 
Objectives  
Upon completion of this section, you should be able to: 
• explain the characteristics of the absorption, distribution, 
metabolism and elimination of TCE in the body. 
Introduction  TCE is readily absorbed following both inhalation and oral exposures. 
Once absorbed, TCE diffuses readily across biological membranes and is 
widely distributed to tissues and organs via the circulatory system. 
Studies in animals and humans have found TCE or its metabolites in 
most major organs and tissues. TCE metabolism occurs primarily in the 
liver and eliminated either unchanged in expired air or by metabolic 




In humans, TCE is rapidly and extensively absorbed by the lungs and 
into the alveolar capillaries(Sato, Nakajima et al. 1977; Monster, 
Boersma et al. 1979; Clewell, Gentry et al. 1995).  
Case reports of human poisoning after ingestion of TCE indicate that 
gastrointestinal absorption is also substantial (Kleinfeld and Tabershaw 
1954; Defalque 1961; Bruning, Vamvakas et al. 1998). 
Because of its lipid solubility, TCE accumulation occurs in organs 
containing high levels of adipose tissue, such as, the lungs, liver, 
kidneys and central nervous system. Consequently, slow release of TCE 
from adipose stores might act as an internal source of exposure, 
ultimately resulting in longer residence times and bioavailability of 
TCE(Fernandez, Droz et al. 1977; Dallas, Gallo et al. 1991; Fisher, 
Gargas et al. 1991; WHO 2005). 
Age-dependent factors may influence TCE distribution in humans, 
suggesting greater susceptibility to TCE in children than in 
adults(Pastino, Yap et al. 2000; WHO 2005). 
Metabolic 
Pathways 
TCE undergoes metabolism by two major pathways (Lash, Fisher et al. 
2000): 
• oxidation by cytochrome P450 enzymes  
• conjugation with glutathione (GSH) by glutathione-S-transferases 
(GSTs) 
The oxidative metabolism of TCE take place primarily in the liver, 
although it may also occur in other tissues, such as the lung(Lash, 
Fisher et al. 2000). 
The principal metabolites derived from oxidation pathway are: 
• chloral hydrate, further metabolized to trichloroethanol (TCOH), 
• trichloroacetic acid (TCA), and 
• dichloroacetic acid (DCA) 
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The GSH conjugation also occurs mainly in the liver by GST, although 
several other tissues (kidney, biliary tract and intestines) are 
involved(Lash, Fisher et al. 2000). 
The metabolites derived from the conjugation pathway are: 
• S-(1,2-dichlorovinyl)glutathione (DCVG) 
• S-(1,2-dichlorovinyl)cysteine (DCVC) (can be further converted to 
other reactive metabolites) 
The mutagenic and carcinogenic potential of TCE is generally thought to 
be due to reactive intermediate biotransformation products rather than 
the parent molecule itself.  
The oxidative metabolites are responsible for the effects on the liver 
(both cancer and non-cancer), whereas the conjugative metabolites may 
preferentially affect other organs (e.g., kidney) (Davidson and Beliles 
1991; Lash, Fisher et al. 2000; WHO 2005). For examples, one of the 
issues of most concern with TCE is its conversion to DCA which is clearly 
carcinogenic in both mice and rats(Chen 2000; Bull, Orner et al. 2002; 
WHO 2005); Dichlorovinylcysteine (DCVC) is mutagenic and may cause 
DNA damage in mammalian cells in vitro and in vivo (NTP 2004). 
However, TCA or DCA is unlikely to be responsible for human liver 
cancer at environmental levels of exposure to TCE(DeAngelo, Daniel et 
al. 1997; WHO 2005). 
One study (Lipscomb, Garrett et al. 1997) reported significant variability 
in TCE metabolism in a sample of 23 human hepatic microsomal 
samples. The results indicate that humans are not uniform in their 
capacity for cytochrome P450-dependent metabolism of TCE. An 
increased activity of this metabolic pathway may increase susceptibility 
to TCE induced toxicity in the human. 
Elimination  Elimination pathways appear to be similar for ingestion and inhalation. A 
relatively small amount of absorbed TCE is exhaled unchanged; most of 
an absorbed dose is metabolized and excreted in the urine, as TCA, 
TCOH or DCV conjugates.  
Studies in human volunteers have shown that after exposure to air 
concentrations between 50 and 380 ppm, approximately 58% of an 
absorbed dose appears in urine as metabolites (Monster, Boersma et al. 
1976; Monster, Boersma et al. 1979). The time between TCE inhalation 
and urinary excretion of trichloroethanol is relatively short (biologic half-
life approximately 10 hours) compared with the urinary excretion of 
trichloroacetic acid (biologic half-life approximately 52 hours). 
Trichloroacetic acid is theoretically detectable in urine for at least a 
week after TCE exposure (Sato, Nakajima et al. 1977; Monster, 
Boersma et al. 1979). 
No studies have provided evidence of saturation of TCE metabolism in 
humans, at least for short-term inhalation exposure to high 
concentrations up to 315 ppm (Agency for Toxic Substances and 
Disease Registry 1997). 
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Although the pathways for metabolism of TCE in mice, rats, and humans 
appear to be qualitatively similar, quantitatively differences among 
species may substantially alter the effective dose of reactive 
metabolite(s) that is delivered to a target organ (Bruckner, Davis et al. 
1989). 
It has been estimated that humans metabolize approximately 20 times 
less TCE on a body weight basis than rats at similar exposure levels. 
Consequently, humans metabolize approximately 60 times less TCE on a 
body weight basis than mice (Goeptar, Commandeur et al. 1995). 
Species differences in TCE metabolism might explain observed 
differences in susceptibility to specific TCE-related diseases. Liver 
cancer, for example, occurs mainly in strains of mice that generate high 
levels of trichloroacetic and dichloroacetic acids as TCE metabolites in 
liver cells. By contrast, rats that metabolize more TCE via glutathione 
conjugation are prone to renal cancer. 
Because of such species-specific effects, caution must be used when 
extrapolating adverse effects from experimental animals to humans 
(Kimbrough, Mitchell et al. 1985; Fan 1988; Goeptar, Commandeur et 
al. 1995; Kaneko, Wang et al. 1997; Lash, Fisher et al. 2000).  
Key Points • Pulmonary and gastrointestinal absorption of TCE is rapid. Because of 
its lipid solubility, TCE accumulation occurs in organs containing high 
levels of adipose tissue, such as, the lungs, liver, kidneys and central 
nervous system. 
• The mutagenic and carcinogenic potential of TCE is thought to be due 
to reactive intermediate biotransformation products rather than the 
parent molecule TCE itself.  
• Because of species difference in TCE metabolism, caution should be 
used in extrapolating adverse effects to humans. 
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8. Which of the following statements about metabolism of an absorbed 
dose of TCE is correct? 
A. a small amount is exhaled unchanged 
B. most of the dose is metabolized in the liver 
C. TCE is excreted in the urine as trichloroacetic acid and 
trichloroethanol 
D. all of the above. 
To review relevant content, see “Half Life” and “Key Points” in this 
section. 
9. Which of the metabolic pathways of TCE is associated with hepatic 
toxicity? 
A. cytochrome P450-dependent oxidation 
B. glutathione (GSH) conjugation 
C. both cytochrome P450-dependent oxidation and glutathione 
(GSH) conjugation 
D. none of the above. 
To review relevant content, see “Metabolic Pathways” in this section. 
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What Are the Physiological Effects of Trichloroethylene? 
Learning 
Objectives 
Upon completion of this section, you should be able to 
• describe the physiological effects associated with TCE exposure. 
Introduction Some occupational studies have shown that TCE produces  
• CNS effects 
• decreased appetite 
• gastrointestinal irritation 
• headaches 
• mucous membrane 
• skin irritation 
Hepatotoxicity has been associated primarily with TCE inhalation and 
ingestion of very large amounts.  
Renal failure has been reported in concert with confirmed hepatic 
damage.  
Cardiac dysrhythmias may be induced by heavy TCE exposure. 
Neurological 
Effects 
TCE-induced CNS symptoms depend on both concentration and exposure 
duration. 
 Acute Exposure 
In one study of human volunteers, exposure to TCE air levels of 27 ppm 
for one to four hours caused drowsiness and mucous membrane 
irritation, and at 81 ppm, headaches (Nomiyama and Nomiyama 1977). 
In another study, an 8-hour exposure (two 4-hour exposures separated 
by 1.5 hours) to 110 ppm TCE for two 4-hr periods resulted in decreased 
performance on tests of perception, memory, reaction time, and 
dexterity (Salvini, Binaschi et al. 1971). However, a later attempt to 
replicate these results found no effects other than fatigue and drowsiness 
(Stewart RD 1974a). 
The available data suggest that the threshold for CNS effects in humans 
is in the range 81-110 ppm TCE, although the effects observed at these 
exposure levels reflected only mild symptoms of CNS depression (Brown, 
Farrar et al. 1990). 
Symptoms due to short-term exposures typically resolve within a few 
hours of exposure. However, one report demonstrated evidence of long-
term residual oculomotor and ciliary reflex dysfunction as well as 
impaired neuropsychological performance as a result of acute TCE 
intoxication (Feldman, White et al. 1985). 
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Chronic Exposure 
In a study of 73 workers employed from one month to 15 years in 
various industrial cleaning and degreasing operations using TCE, 
complaints due to chronic exposure included: 
• a reduced number of word associations, 
• ataxia, 
• decreased appetite, 
• headache, 
• short-term memory loss, 
• sleep disturbances, and 
• vertigo 
Greater frequency of symptoms was noted in workers exposed to higher 
(85 ppm) than lower (14 ppm) mean TCE concentrations (Grandjean, 
Munchinger et al. 1955). 
Some of the observed neurological effects from long-term exposure to 
TCE indicate impaired trigeminal nerve function (e.g., blink reflex and 
masseter reflex) (Buxton and Hayward 1967; Agency for Toxic 
Substances and Disease Registry 1997). This is thought to be 
neurotoxicity induced dichloroacetylene, a breakdown product of TCE 
(Armstrong and Green 2004). 
A study found neurobehavioral deficits from exposures to drinking water 
contaminated with to TCE (Reif, Burch et al. 2003). 
Deliberate Abuse 
Abuse of volatile chlorocarbon solvents is a risk factor for development of 
cerebellar damage and ataxia. 
Animal Studies 
Studies on the neurological effects of acute TCE inhalation in animals 
have produced results similar to human studies (Agency for Toxic 
Substances and Disease Registry 1997). 
Gastrointestin
al, Hepatic and 
Renal Effects 
When swallowed, TCE causes gastrointestinal (GI) irritation, with possible 
inflammation of the GI tract, manifested as: 
• abdominal pain 
• diarrhea  
• nausea 
• vomiting 
Hepatotoxicity has been associated primarily with intentional TCE 
inhalation abuse. In these cases, hepatic histological examination has 
revealed centrilobular necrosis with fatty infiltration (Joron, Cameron et 
al. 1955; Thiele, Eigenbrodt et al. 1982). 
Page 26 of 57 
Agency for Toxic Substances and Disease Registry Trichloroethylene Toxicity 
Case Studies in Environmental Medicine (CSEM) 
 
Chronic TCE exposures at concentrations currently permissible in the 
workplace or at those expected in ambient air are not likely to cause liver 
damage (Agency for Toxic Substances and Disease Registry 1997). 
Studies that have examined exposure to TCE and development of kidney 
disease (Lash, Parker et al. 2000). 
• One case report links acute renal failure with normal liver function in a 
male worker opening bins containing 7.5 L of a nearly pure solution of 
TCE (David, Wolman et al. 1989). 
• One study reports that adverse kidney effects associated with 
occupational exposure to TCE are very mild (Nagaya, Ishikawa et al. 
1989). 
• Another study of a small group of male metal degreasers in Sweden 
observed no increase in N-acetyl-β-glucosamineidase (NAG) excretion 
into urine, and concluded that TCE was not nephrotoxic at low 
exposures levels (Selden, Hultberg et al. 1993). 
• A retrospective study was performed on 39 workers who were 
exposed to high levels of TCE from 1956 to 1975. The study concluded 
that chronic exposure to high doses of TCE causes persistent changes 
to the proximal tubules (Bruning, Sundberg et al. 1999). 
• In a recent cross-sectional study of 70 workers currently exposed to 
TCE, the mean exposure to TCE, estimated from urinary 
trichloroacetic acid concentrations, was 32 ppm (range 0.5 – 252 
ppm) with average duration of exposure of 4.1 years (range 1-20 
years). The results suggested that kidney damage could occur at 
exposure concentrations higher than 250 ppm (Green, Dow et al. 
2004). 
• A study reports on a 17-year-old male who ingested approximately 70 
ml TCE in a suicide attempt. This study first demonstrated that a 
single, oral dose of TCE can produce nephrotoxicity in humans 
(Bruning, Vamvakas et al. 1998). 
Cardiac Effects A few case studies of persons who died following acute occupational 
exposure to TCE have revealed cardiac arrhythmias to be the apparent 
cause of death(Kleinfeld and Tabershaw 1954; Smith 1966). 
When TCE was administered as an anesthetic agent, serious ventricular 
arrhythmias and cardiac arrests were rare and were nearly always 
associated with hypoxia(Norris and Stuart 1957). 
Significant ventricular ectopy would not be expected from TCE exposure 
at background environmental levels or those currently allowed in the 
workplace (Candura and Faustman 1991). 
The underlying mechanism of these cardiac effects of TCE exposure 
might be due to changed sensitization of the heart to catecholamines 
(Agency for Toxic Substances and Disease Registry 1997). 
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Adverse effects were noted in residents of several communities where 
TCE was found to be present in drinking water (Bove, Shim et al. 2002). 
The Tucson study (1990) (Goldberg, Lebowitz et al. 1990) reported a 
higher risk of congenital cardiac defects associated with exposure to TCE-
contaminated drinking water. The New Jersey study (1995) (Bove, 
Fulcomer et al. 1995) reported a strong association between exposure to 
TCE-contaminated drinking water and oral clefts as well as neural tube 
defects (NTDs). The Woburn study (1996) (Massachusetts Department of 
Public Health 1996) found associations between exposures to TCE-
contaminated well water and small for gestational age (SGA), fetal 
deaths, eye defects, choanal atresia, NTDs, cleft lip, and hypospadias. 
The Camp LeJeune study (1998) also found increased risk of SGA 
associated with TCE (Bove, Shim et al. 2002). 
One retrospective occupational study suggested an increased risk of 
spontaneous abortion in women exposed to TCE, but the result was not 
statistically significant, and the effect disappeared when odds ratios were 
adjusted for potential confounders (Windham, Shusterman et al. 1991). 
In animals, some abnormalities (decreased fetal body weight, ossification 
anomalies, and cardiac defects) have been reported infrequently (Agency 
for Toxic Substances and Disease Registry 1997). 
Carcinogenic 
Effects 
Evidence for the carcinogenicity of TCE in humans comes from several 
cohort studies where specific TCE exposures were well characterized for 
individual study subjects. 
A meta-analysis of these cohort studies found that occupational exposure 
to TCE was associated with excess incidences of liver cancer, kidney 
cancer, non-Hodgkin’s lymphoma, prostate cancer, and multiple 
myeloma, with the strongest evidence for the first three cancers 
(Wartenberg, Reyner et al. 2000; NTP 2004). It is important to note that 
the conclusions drawn in these studies were based on a relatively small 
number of exposed workers and were confounded by exposure to other 
solvents and other risk factors. Other studies did not reveal any excess 
cancer mortality from low exposures to TCE (Axelson, Andersson et al. 
1978; Tola, Vilhunen et al. 1980; Shindell and Ulrich 1985; Spirtas, 
Stewart et al. 1991; Axelson, Selden et al. 1994).  
A study (Massachusetts Department of Public Health 1996) performed in 
Woburn, Massachusetts by the Massachusetts Department of Health 
(1996) found an elevated risk of childhood leukemia in a group exposed 
to TCE in uterus. 
The New Jersey study (Bove, Fulcomer et al. 1995) found associations 
with childhood leukemia among females and with non-Hodgkin’s 
lymphoma. 
A review on mutagenicity of TCE and its metabolites indicated that TCE 
and its metabolites are not potent genotoxic agents and require high 
doses to induce a response (Moore and Harrington-Brock 2000). The full 
tumor development is likely to require promotional stimuli under high 
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(suggested: >500 ppm peak exposures) and long-term (several years) 
exposure to TCE (Bolt, Lammert et al. 2004). 
A cohort study of 169 male workers having been exposed to unusually 
high levels of TCE in Germany between 1956 and 1975 supported a 
nephrocarcinogenic effect of TCE in humans. A further case-control study 
confirmed the results of the previous cohort study, supporting the 
concept of involvement of prolonged and high-dose TCE exposures in the 
development of renal cell cancer (Bruning and Bolt 2000). The finding of 
a TCE-specific mutation of the von Hippel-Landau (VHL) tumor 
suppressor gene, a gene associated with kidney tumors, provides strong 
evidence that TCE causes kidney cancer (Brauch, Weirich et al. 1999). 
A study of three Michigan communities exposed to chlorinated solvents, 
including TCE in drinking water, showed no significant increase in 
cancers, including leukemia, among the exposed population. However, 
the cohort size in the study was only 223 (Agency for Toxic Substances 
and Disease Registry 1997). A study of 4,280 people exposed to TCE and 
other contaminants in drinking water in three states reported an increase 
in respiratory tract cancer in males. The study authors concluded that, 
based on the incidence of smoking in the population, “it would be 
inappropriate to relate this excess solely to TCE exposure” (Agency for 
Toxic Substances and Disease Registry 1997). 
The findings in humans are supported by evidence of carcinogenicity in 
experimental animals, in which tumors occurred at several of the same 
sites as in humans. Inhalation or oral exposure to high doses of TCE 
produces liver and lung tumors in mice (Maltoni, Lefemine et al. 1988), 
and renal adenocarcinomas, testicular tumors, and possibly leukemia in 
rats (Maltoni, Lefemine et al. 1988). 
However, it is important to understand interspecies differences in TCE 
metabolism and pharmacokinetics in order to reduce uncertainties 
inherent in species-to-species extrapolations (Bruckner, Davis et al. 
1989). 
Many studies reviewed by the International Agency for Research on 
Cancer (IARC) examined the relationship between TCE exposure and 
kidney and liver cancer mortality or incidence. Most of studies were of 
occupational exposures (Bull 2000; Lash, Parker et al. 2000). 
In conclusion, TCE is reasonably anticipated to be a human carcinogen 
based on limited evidence of carcinogenicity from studies in humans, 
sufficient evidence of carcinogenicity from studies in experimental 
animals, which indicates there is an increased incidence of malignant 
and/or a combination of malignant and benign tumors at multiple tissue 
sites in multiple species of experimental animals, and information 
suggesting TCE acts through mechanisms that indicate it would likely 
cause cancer in humans (NTP 2004). 
Other Effects Respiratory 
TCE produces minimal irritation of the respiratory tract at concentrations 
that do not exceed current workplace standards (Waters, Gerstner et al. 
1977). 
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TCE is not a sensitizing agent, and bronchospasm is unlikely to occur 
except after exposure to high concentrations (Agency for Toxic 
Substances and Disease Registry 1997). Reactive Airway Dysfunction 
Syndrome (RADS) or Irritant Induced Asthma (IIA) has been attributed 
to exposure to very high concentrations of solvents (Rosenman, Reilly et 
al. 2003). 
In a study conducted with human volunteers, 200 ppm TCE was inhaled 
simultaneously with ethanol ingestion, an increase in both heart rate and 
breathing rate was observed. However, when 200 ppm TCE was inhaled 
in the absence of ethanol ingestion, these TCE-related effects did not 
occur (Agency for Toxic Substances and Disease Registry 1997). 
TCE is both acutely toxic and carcinogenic to the mouse lung following 
exposure by inhalation. Toxicity to the mouse lung is confined almost 
exclusively to the nonciliated Clara cell (Forkert, Sylvestre et al. 1985). 
Comparisons between species suggest that the ability of the human lung 
to metabolize TCE is approximately 600-fold less than that in the mouse. 
In addition, the human lung differs markedly from the mouse lung in the 
number and morphology of its Clara cells. Thus, risks from TCE exposure 
to human lung damage are minimal (Green 2000). 
Skin 
Like other organic solvents, TCE may produce contact dermatitis, rashes, 
and burns. The defatting dermatitis resulting from prolonged contact may 
reduce resistance to skin infections. An irritant reaction resembling an 
exfoliative dermatitis or scarlatiniform reaction can occur from dermal 
contact with contaminated clothing (Waters, Gerstner et al. 1977; 
Agency for Toxic Substances and Disease Registry 1997). 
A syndrome called degreaser's flush (Stewart, Hake et al. 1974) has 
been associated with the interaction of ingested ethanol and inhaled TCE. 
Typically, erythema resulting from vasodilation develops around the face, 
back, and shoulders within 30 minutes of exposure and resolves in about 
an hour. 
Immune System 
The immunotoxic effects of TCE were evaluated in an animal study. The 
investigators concluded that, although the effects observed were not 
remarkable, the immune system does appear to be sensitive to the 
chemical (Sanders, Tucker et al. 1982). A few reports have been found 
on human immunological abnormalities related to usage of TCE 
contaminated well water(Byers, Levin et al. 1988; Kilburn, Warshaw et 
al. 1992; Waller, Clauw et al. 1994). A recent study of TCE exposed 
workers has found immune abnormalities (Iavicoli, Marinaccio et al. 
2005). 
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• CNS depression is the most prominent effect of acute TCE exposure. Key Points 
• Chronic occupational TCE exposure has been associated with 
neurological abnormalities. 
• Case reports associate liver damage with inhalation of high levels of 
TCE. 
• Renal toxicity has been described in the literature but would not be 
expected from ambient air exposure. 
• Significant cardiac effects would not be expected from TCE exposure 
at background environmental levels or those currently allowed in the 
workplace. 
• Several studies have reported reproductive or developmental 
abnormalities thought to be associated with exposure to TCE in 
drinking water. 
• TCE is reasonably anticipated to be a human carcinogen based on 
limited evidence of carcinogenicity from studies in humans, sufficient 
evidence of carcinogenicity from studies in experimental animals, 
which indicates there is an increased incidence of malignant and/or a 
combination of malignant and benign tumors at multiple tissue sites 
in multiple species of experimental animals, and information 
suggesting TCE acts through mechanisms that indicate it would likely 
cause cancer in humans (NTP 2004). 




10. Trichloroethylene has been associated with all of the following types 
of cancer in humans except for 
A. liver cancer 
B. brain cancer  
C. Non-Hodgkin’s lymphoma 
D. kidney cancer. 
To review relevant content, see “Carcinogenic Effects” in this section. 
11. The reported cranial neuropathic effects of TCE exposure include 
A. sensorineural hearing loss 
B. trigeminal functional losses 
C. Bells Palsy 
D. color vision loss. 
To review relevant content, see “Neurological Effects” in this section. 
12. Which of following statements is correct? 
A. Comparisons between species suggest that the ability of the 
human lung to metabolize TCE is much greater than that in the 
mouse. 
B. Inhalation or oral exposure to high doses of TCE for a prolonged 
period is likely to induce liver and lung tumors in both animals 
and humans. 
C. TCE and its metabolites are potent genotoxic agents. 
D. none of the above. 
To review relevant content, see “Carcinogenic Effects” in this section. 
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How Should Patients Exposed to Trichloroethylene Be Evaluated? 
Learning 
Objectives  
Upon completion of this section, you should be able to: 
• identify the primary focuses of the exposure history, 
• describe the characteristic finding on patient examination, and 
• describe characteristic clinical presentations of patients with acute or 
chronic TCE exposure. 
Introduction When considering the human health effects of TCE, it is important to 
make a distinction between occupational exposures to relatively high 
levels by inhalation and general environmental exposures to low levels in 
drinking water and ambient air. 
Patient History An occupational history should be routinely obtained. It should include 
items such as: 
• company name and location 
• job title 
• description of chemical processes encountered 
• known toxic agents used 
• workplace investigations 
• complaints of co-workers 
An environmental history should also be obtained, including: 
• location and duration of residence 
• proximity to industry 
• diet 
• daily activities 
• type of water supply 
• use of consumer products that contain TCE 
If a temporal association between symptoms and exposure to certain 
products is suspected, an attempt should be made to identify the specific 
chemical ingredients involved. In the situation involving occupational or 
consumer product exposure, if the product label does not list the 
chemical ingredients, the regional poison control center may maintain a 
list of ingredients in consumer and proprietary products. In the U.S.: call 
1-800-222-1222, or check http://www.aapcc.org/ for an updated list of 
U.S. Poison Control Centers. The World Health Organization and the 
International Program on Chemical Safety maintain an international list 
of poison control centers: 
http://www.who.int/ipcs/poisons/centre/directory/en/index.html  
In occupational exposures in the U.S., the employer or manufacturer is 
required by law to provide a material safety data sheet (MSDS), which 
lists the chemical ingredients and describes their potential toxicity. 
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The patient's complaints should be identified in terms of onset, duration, 
and intensity. Complaints should be investigated by focusing first on 
major organ systems that are likely to be affected by exposure to TCE 
(CNS, hepatic, integumentary, cardiovascular, renal), and then on 
systems unlikely to be affected (respiratory, gastrointestinal, endocrine, 
skeletal). 
Vital signs should be recorded, especially abnormalities of heart rate or 
rhythm. Eyes, nose, throat, and skin should be examined carefully for 
inflammation or irritation. The conjunctiva may be injected, and nasal 
mucosa may be injected and swollen. Repeated inhalation exposures to 
trichloroethylene can cause defatting of nasal mucosa, leading to a 
friable condition with drying, cracking, or bleeding. Skin contact may 
cause dermatitis by irritation and defatting. 
The patient's abdomen should be palpated for hepatomegaly and right 
upper quadrant tenderness. 
Patients should receive a complete neurological examination, including a 
mental status exam and evaluation of the cranial nerves, to detect either 
peripheral or central nervous system involvement. Cranial neuropathies 
in patients with a history of TCE exposure are uncommon. 
Signs and 
Symptoms 
No unique pattern of symptoms characterizes TCE-induced illness. 
Acute Exposure 
 
With inhalation of high concentrations, TCE causes initial CNS excitation 
followed by CNS depression. Depending on the duration and intensity of 
exposure, symptoms (Meditext 2004) can include: 
• ataxia, 











• pulmonary edema, 
• renal and hepatic damage, 
• respiratory depression, 
• seizures, 
• stupor, and  
• visual disturbances 
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Coma and respiratory depression may occur with prolonged, high-level 
exposure (i.e., above 2,000 ppm). Serious ventricular arrhythmias can 
develop up to 24 hours after large TCE ingestions (Agency for Toxic 
Substances and Disease Registry 1997). 
Effects from ingestion include: 
• abdominal pain, 











• partial paralysis, 
• somnolence, and  
• vomiting 
The main systemic response is CNS depression (Meditext 2004). 
TCE is a skin irritant and may cause defatting dermatitis of the skin. 
Scleroderma has been linked with TCE exposure. Dermal absorption is 
not likely to be significant if dermatitis is prevented. Vasodilation and 
malaise ('degreasers flush') recur in workers who drink ethanol after 
exposure to TCE (Meditext 2004). 
After any type of acute exposure, the clinician should keep in mind that: 
• because respiratory depression is the most common serious sequela 
of acute TCE exposure, the adequacy of ventilation should be 
carefully assessed, 
• because of possible arrhythmias, patients with preexisting 
cardiovascular disease should be monitored by continuous 
electrocardiogram and frequent evaluation of vital signs, and 
• because hepatic injury may occur, liver function tests should be 
performed. 
Chronic Exposure 
The symptoms seen in humans in cases of long-term exposure were 
similar to those seen in acute exposure, but occurred in more extreme 
and persistent forms (Kleinfeld and Tabershaw 1954; Fan 1988).  
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Reported neurological effects associated with chronic workplace exposure 
to TCE have included nonspecific symptoms such as: 
• ataxia, 
• decreased appetite, 
• dizziness, 
• emotional instability, 
• fatigue, 
• headache, 
• impaired judgment, 
• memory loss, 
• sleep disturbances, and  
• weakness 
WHO (1985) noted that chronic effects such as disturbance of the 
nervous system can occur following prolonged exposure to TCE 
concentrations of about 100 ppm (WHO 1985).  
Although some CNS symptoms may disappear within several weeks after 
cessation of exposure, other CNS adverse health effects such as memory 
loss and mood swings may persist in persons who have been exposed to 
TCE for long periods (Agency for Toxic Substances and Disease Registry 
1997). 
Persistent neurological symptoms suggest the possibility of psychiatric 
disorders and also prompt a search for exposure to neurotoxicants, such 
as alcohol and other drugs of abuse. 
Key Points • TCE exposure produces no unique clinical clues. 
• Respiratory depression can result from acute, high-dose TCE 
exposure. 
• At permissible workplace levels, CNS symptoms of TCE exposure are 
usually nonspecific and transient. 
Progress 
Check 
13. A temporal association between symptoms and exposure to certain 
products is one of the focuses of patient history because: 
A. it helps evaluate general health  
B. it helps find out patient history on alcohol and drug use 
C. it helps provide important clues on the cause 
D. all of the above 
To review relevant content, see “Patient History” in this section. 
14. On patient examination, short-term memory loss, if associated with 
TCE exposure, is generally: 
A. irreversible 
B. reversible 
C. similar to the forms of dementia 
D. the initial symptom of acute exposure 
To review relevant content, see “Signs and Symptoms” in this section. 
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15. Symptoms associated with inhalation of high-level TCE may include 





To review relevant content, see “Signs and Symptoms” and “Acute 
Exposure” in this section. 
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Upon completion of this section, you should be able to: 
• identify direct and indirect measurements that can assist with 
diagnosis of TCE exposure. 
Introduction TCE may be measured to confirm TCE exposure. Significant exposure to 
TCE may result in elevated values of routine laboratory tests, including 




Directly testing for TCE in the blood can be used for either immediate 
exposure or chronic exposure. However there are multiple factors that 
influence these results, including time when the sample was taken, total 
body fat, activity level, and enzyme activity of aldehyde and alcohol 
dehydrogenase (Waksman and Phillips 2004). Detectable plasma levels 
of TCE in persons without occupational exposure are approximately 0.01 
to 0.13 micrograms per deciliter (µg/dL). 
TCE Metabolites 
Although TCE disappears rapidly from the blood, metabolites (e.g., 
trichloroacetic acid) can persist in the blood for several weeks and in 
urine up to three weeks after heavy exposure (Sato, Nakajima et al. 
1977; Monster, Boersma et al. 1979). Immediate exposure is best 
measured by trichloroethanol levels in the blood. Chronic exposure is 
best measured by urinary trichloroacetic acid (Waksman and Phillips 
2004). 
Caution 
The presence of TCE metabolites should be interpreted with caution 
because some medications (chloral hydrate and disulfiram) and other 
chlorinated hydrocarbons (1,1,1-trichloroethane and tetrachloroethylene) 
are also metabolized to trichloroacetic acid and excreted in the urine 







Urinary excretion of glutathione-S-transferase alpha (Bruning, Sundberg 
et al. 1999), α1-microglobulin (Bolt, Lammert et al. 2004), β2-
microglobulin (Nagaya, Ishikawa et al. 1989) and N-acetyl-β-D-
glucosaminidase (Brogren, Christensen et al. 1986; Selden, Hultberg et 
al. 1993) are used to indicate kidney damage, but neither marker is 
specific to TCE-induced damage; a number of short-chain halogenated 
hydrocarbons can produce similar effects (Agency for Toxic Substances 
and Disease Registry 1997). 
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Liver 
Biochemical abnormalities are uncommon after acute TCE exposures. 
Rarely have elevations of serum hepatic transaminases (serum glutamic-
oxaloacetic transaminase (SGOT) or aspartate aminotransferase (AST), 
serum glutamic-pyruvic transaminase (SGPT) or alanine 
aminotransferase (ALT)), bilirubin, and creatinine resulted from acute 
TCE exposure; (Rasmussen, Brogren et al. 1993; Agency for Toxic 
Substances and Disease Registry 1997) nevertheless, liver and kidney 
function and serum creatinine tests should be performed to establish 
baselines. 
Heart 
Electrocardiogram and continuous cardiac monitoring should be 
considered for heavily exposed persons. 
Gastrointestinal 
Ingestion of large amounts of TCE, which can cause profuse diarrhea, 
can produce an electrolyte imbalance. 
Nervous System 
Because the trigeminal, optic, and facial nerves can be impaired by 
exposure to dichloroacetylene, changes in the visual fields and trigeminal 
nerve potentials can be noted (Szlatenyi and Wang 1996). 
Immune System 
Two studies that may be of value are Kahn and Letz (1989) and 
American College of Physicians (1989). 
If it had been indicated, laboratory evaluation of immunologic host-
defense defects would consist of three phases. 
The preliminary screening is a complete blood count with differential 
smear and quantitative immunoglobulin levels. These tests, together with 
history and physical examination, will identify more than 95% of patients 
with primary immunodeficiencies. 
The second testing phase consists of readily available studies including 
B-cell function (such as antibodies and response to immunization), T-cell 
function (skin tests and contact sensitization), and complement levels. 
The first two phases combined will detect most immunodeficiencies 
amenable to conventional treatment with gamma globulin or plasma.  
The third phase (in-depth investigation) consists of testing induction of 
B-lymphocyte differentiation in vitro, stimulated by pokeweed mitogen 
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and histological and immunofluorescent examination of biopsy 
specimens; T-cell surface markers; assays of T-cell helper or killer cell 
functions; and functional assays using appropriate target cells. It is 
inappropriate to perform the latter tests on environmentally exposed 
patients except for epidemiologic research. 
If the patient’s concerns include an increased risk of autoimmune 
illnesses, general evaluation for autoimmune diseases might include 
• C-reactive protein (CRP), 
• evaluation of the antinuclear antibody (ANA), and  
• the erythrocyte sedimentation rate (ESR). 
If a specific autoimmune disease is suspected, appropriate serologic 
markers should be assessed, where available. 
Key Points • TCE can be detected in the breath and urine up to 16 hours after 
exposure; metabolites can persist for a week or more. 
• Urinary metabolites are trichloroethanol and trichloroacetic acid. 
• Urinary proteins, liver function tests, a serum creatinine test, and 
continuous cardiac monitoring should be considered for persons 
acutely exposed to high levels of TCE. 
Progress 
Check 
16. To confirm TCE exposure, which of the following measurements is the 
most reliable testing? 
A. trichloroacetic acid in blood and urine 
B. TCE in breath, blood, or urine 
C. elevated values of renal and liver function tests 
D. elevated values of routine laboratory tests. 
To review relevant content, see “Direct Biologic Indicators” in this 
section. 
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How Should Patients Exposed to Trichloroethylene Be Treated and Managed? 
Learning 
Objectives 
Upon completion of this section, you should be able to: 
• describe the principal treatment strategy for treating and managing 
TCE poisoning. 
Introduction There is no antidote for TCE poisoning. Treatment consists of support of 
respiratory and cardiovascular functions. 
Acute 
Exposure 
In the case of dermal contact with liquid TCE, contaminated clothes 
should be removed and the affected areas washed with copious amounts 
of soap and water. Direct eye splashes require irrigation for at least 15 
minutes. Corneal epithelium damage usually resolves spontaneously 
after irrigation. 
 
Patients should be removed from the contaminated environment as soon 
as possible; begin artificial ventilation, if needed. Those with altered 
mental status or apparent respiratory insufficiency should receive 
supplemental oxygen. If the patient's pulse is absent, cardiopulmonary 
resuscitation should be initiated. 
Gut decontamination (emesis, lavage, or saline cathartic) is 
recommended if it can be initiated within two to three hours after the 
ingestion of more than a swallow of TCE. However, the effects of these 
measures have not been clinically evaluated. If emesis is considered, 
administer the emetic only to patients who are fully conscious and have 
an intact gag reflex. Activated charcoal has not been proven to absorb 
TCE, but, in general, it effectively decreases absorption of most ingested 
toxic agents.  
• No data are available on the ability of hemodialysis or hemoperfusion 
to increase TCE elimination.  
• No specific antidotes exist (Meditext 2004). 
• Patients with serious TCE toxicity should be monitored for the 
possible development of arrhythmias.  
• When diarrhea is present, monitor for the development of electrolyte 
abnormalities and screen for the possible development of hepatorenal 
dysfunction (Meditext 2004). 
• Sequelae are unusual in acute exposures but reported (Lawrence and 





No known treatment for chronic exposure to TCE exists. Potentially 
involved organ systems should be independently evaluated, and 
supportive measures should be initiated. 
Key Points • Removal from the source and supportive care is the recommended 
treatment for acute TCE exposure. 
• Symptomatic treatment is recommended for chronic TCE exposure. 
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17. The primary strategy for managing TCE poisoning patients includes 
A. supportive measures 
B. ventilation therapy 
C. reduction or elimination of exposure 
D. all of the above. 
To review relevant content, see “Introduction” and “Acute Exposure” in 
this section. 
18. All of following statements are correct except: 
A. Symptoms related to chronic exposure tend to worsen during 
exposure and improve when exposure ceases. 
B. CNS symptoms due to acute TCE inhalation exposure are 
transient but may linger for hours after exposure ceases. 
C. Supportive care directed to adequate ventilation and circulation 
should be provided. 
D. There is a specific antidote for TCE poisoning. 
To review relevant content, see “Chronic Exposure” in this section. 
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What Instructions Should Be Given to Patients? 
Learning 
Objective 
Upon completion of this section, you should be able to: 
• describe advice on self care and follow-up care normally provided to 
patients who are exposed to TCE. 
Introduction All patients exposed to TCE need some basic guidance on: 
• self care, so they can minimize further risks and avoid complications 
to the extent possible and 
• clinical follow up, so they understand when and why to return for 
further medical attention. 
ATSDR has developed a patient education sheet on TCE that you might 
find useful. It can be found at [add URL for patient education] 
Self Care Patients should be advised to avoid exposures and conditions that might 
further increase their risk of disease or worsen their existing condition. 
At work 
• Be sure to use personal protective equipment (PPE) - gloves, goggles, 
masks. 
• Ask employer for the MSDS on products that you use. 
• Be sure all containers are labeled for any chemical you use at work.  
• Ask your employer for training on how to use chemicals at work. 
• Your employer is required to provide labeling, MSDS and training as 
part of the OSHA Hazard Communication Standard. It’s the law! 
At home 
• Search for safer alternatives to products with TCE.  
• When using consumer products containing TCE, open all windows and 
use fans in your workspace. 
• Use respirators or gloves. 
• Use cold water to wash dishes, clothes, etc. 
• Ventilate the bathroom when showering. 
Clinical Follow 
Up 
Since TCE has been implicated as a likely cause of cancer, periodic 
physical exams may be of value in detecting abnormalities at an early 
stage if they occur. 
Patients should be advised to consult their physician if they develop: 
• any sign or symptom of central nervous system or 
• signs or symptoms of other health changes (especially those 
possibly related to heart, liver, and kidney problems) 
ATSDR’s patient education sheet on TCE includes a more detailed 
checklist that you can use to indicate which types of follow up are 
relevant for a given patient. 
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Key Points • Patients should be advised to avoid exposures and conditions that 
might further increase their risk of disease or worsen their existing 
condition. 
• Patients should contact their physician if they develop neurological 
problems or other health changes. 
Progress 
Check 
19. Patients who have been exposed to TCE should 
A. speak to their employer about PPE (if exposures are occupational)  
B. learn how to avoid further exposure  
C. know when to call their doctor 
D. all of the above. 
To review relevant content, see all content in this section. 
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Where Can I Find More Information? 
For More 
Information 
Please refer to the following Web resources for more information on the 
adverse effects of TCE, the treatment of TCE poisoning, and 
management of persons exposed to TCE. You may also contact ATSDR 
(see URLs provided below), your state and local health departments, and 
university medical centers. 
Association of Occupational and Environmental Clinics 
http://www.aoec.org
American College of Occupational and Environmental Medicine 
http://www.acoem.org
American College of Medical Toxicologists 
http://www.acmt.net
American College of Preventive Medicine: 
http://www.acpm.org
ATSDR Information Center 
http://www.atsdr.cdc.gov/icbkmark.html
ATSDR Information Center Contact Information 
http://www.atsdr.cdc.gov/contacts.html
 
Other CSEMs  Case Studies in Environmental Medicine: Trichloroethylene Toxicity is one 
monograph in a series. To view the Taking an Exposure History CSEM 
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Posttest 
Introduction ATSDR seeks feedback on this course so we can asses its usefulness and 
effectiveness. We ask you to complete the assessment questionnaire 
online for this purpose. You can receive continuing education credits as 




Accreditation Council for 
Continuing Medical 
Education (ACCME)
The Centers for Disease Control and Prevention (CDC) is 
accredited by the Accreditation Council for Continuing Medical 
Education (ACCME) to provide continuing medical education for 
physicians. CDC designates this educational activity for a 
maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians 
should only claim credit commensurate with the extent of their 
participation in the activity. 
American Nurses 
Credentialing Center 
(ANCC), Commission on 
Accreditation
This activity for 1.5 contact hours is provided by the Centers for 
Disease Control and Prevention, which is accredited as a provider 
of continuing education in nursing by the American Nurses 
Credentialing Center's Commission on Accreditation. 




CDC is a designated provider of continuing education contact 
hours (CECH) in health education by the National Commission for 
Health Education Credentialing, Inc. The Centers for Disease 
Control and Prevention is a designated provider of continuing 
education contact hours (CECH) in health education by the 
National Commission for Health Education Credentialing, Inc. 
This program is a designated event for the Certified Health 
Education Specialist (CHES) to receive 1.5 Category I contact 
hours in health education, CDC provider number GA0082. 
Disclaimer In compliance with continuing education requirements, all presenters 
must disclose any financial or other relationships with the manufacturers 
of commercial products, suppliers of commercial services, or commercial 
supporters as well as any use of unlabeled product(s) or product(s) 
under investigational use. 
CDC/ATSDR, our planners, and the presenters for this seminar do not 
have financial or other relationships with the manufacturers of 
commercial products, suppliers of commercial services or commercial 
supporters. This presentation does not involve the unlabeled use of a 
product or product under investigational use. 
International Association 
for Continuing Education 
and Training (IACET)
The Centers for Disease Control and Prevention (CDC) has been 
reviewed and approved as an Authorized Provider by the 
International Association for Continuing Education and Training 
(IACET), Suite 800, McLean, VA 22102. CDC will award 0.1 of 
CEU's to participants who successfully complete this program. 
Instructions To complete the assessment and posttest, go to www2.cdc.gov/atsdrce/ 
and follow the instructions on that page. 
You can immediately print your continuing education certificate from 
your personal transcript online. No fees are charged. 
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Please select the 
best correct 
answer 
1. Which of the following products contain trichloroethylene?  
A. Anesthetic. 
B. Grain fumigant. 
C. Spot remover. 
D. Disinfectant. 
2. People can be exposed to trichloroethylene from  
A. Environmental sources. 
B. Consumer products. 
C. Occupational sources. 
D. All of the above. 
3. The common sources of non-occupational exposure to TCE are  
A. Discharge to surface waters and groundwater by industry. 
B. Leaching from hazardous water landfills into groundwater. 
C. Continual volatilization of TCE from emission sources. 
D. All of the above. 
4. Which of the following persons have an increased likelihood of 
trichloroethylene exposure?  
A. Racecar drivers. 
B. Fabric cleaners. 
C. Pharmacists. 
D. Tree sprayers. 
5. NIOSH considers trichloroethylene a potential occupational carcinogen 
and recommends exposure limit of which as a 10-hour TWA  
A. 25 ppm. 
B. 100 ppm. 
C. 50 ppm. 
D. None of the above. 
6. Which of the following statements about trichloroethylene is true?  
A. A large amount of absorbed TCE is exhaled unchanged. 
B. Once absorbed, TCE is slowly cleared from the blood.  
C. Most of an absorbed dose is metabolized in the liver. 
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7. Which of the following statements is not correctly described with 
regards to TCE metabolism?  
A. TCE accumulation occurs in organs containing high levels of 
adipose tissue. 
B. Humans are uniform in their capacity for metabolism of TCE. 
C. The pathways for metabolism of TCE in humans, rats, and mice 
are qualitatively similar. 
D. Humans metabolize much less TCE on a body weight basis than 
rats or mice at similar exposure levels. 
8. Common clinical effects associated with acute exposure to pure TCE 
at concentrations > 2,000 ppm include  
A. CNS depression. 
B. Nausea. 
C. Upper respiratory tract and eye irritation. 
D. All of the above. 
9. Chronic exposure to TCE might  
A. Cause headaches or drowsiness. 
B. Mildly alter liver function. 
C. Cause short-term memory deficits. 
D. All of the above. 
10. The main systemic response to TCE exposure is  
A. Respiratory depression. 
B. CNS depression. 
C. Gastrointestinal irritation. 
D. Skin irritation. 
11. Laboratory tests to confirm TCE exposure include  
A. Breath analysis for trichloroacetic acid. 
B. Cardiac isoenzymes. 
C. Blood analysis for trichloroethanol. 
D. Urinary creatinine. 




D. Milk of magnesia. 
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To review content relevant to the posttest questions, see: 
Question Location of Relevant Content 
1 What is trichloroethylene? 
2 Where is trichloroethylene found? 
3 How are people exposed to trichloroethylene? 
4 Who’s at risk of trichloroethylene exposure? 
5 What are U.S. standards for trichloroethylene exposure? 
6 What is the biologic fate of trichloroethylene in the body? 
7 What is the biologic fate of trichloroethylene in the body? 
8 What are the physiological effects of trichloroethylene? 
9 What are the physiological effects of trichloroethylene? 
10 How should patients exposed to trichloroethylene be evaluated? 
11 What laboratory tests can assist in the evaluation of patients exposed to 
trichloroethylene? 
12 How should patients exposed to trichloroethylene be treated and 
manage? 
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Answers to Progress Check Questions 
1. The best choice is D. TCE (Cl2C=CHCl) is a clear, colorless, nonflammable liquid 
possessing a sweet, fruity odor characteristic of chloroform. 80% of TCE is used for 
vapor degreasing of fabricated metal parts in the automotive and metal industries. 
Before its ban for certain applications in 1977, TCE was also used as a general 
anesthetic (mostly in obstetric settings), grain fumigant, disinfectant, pet food additive, 
and extractant of spices in foods and caffeine in coffee. 
2. The best choice is D. Because of its widespread use, TCE has become a common 
environmental contaminant. Contamination results from evaporative losses during use; 
discharge to surface waters and groundwater by industry, commerce, and individual 
consumers; leaching from hazardous waste landfills into groundwater; and from the 
incidental addition of TCE during food production. 
3. The best choice is B. The air pathway is the most common route of exposure to 
trichloroethylene, and the route that most commonly leads to illness. 
4. The best choice is D. Increased potential for exposure may be encountered by workers 
performing degreasing and metal cleaning shoemakers, rubber cementers, dry cleaners, 
etc. 
5. The best choice is D. It’s unnecessary for those workers from answers A-C to entail high 
risk of exposure to trichloroethylene. Mechanics who degrease fabricated metal parts in 
the automotive industries, however, certainly bear a higher risk of exposure to TCE. 
6. The best choice is B. The current OSHA 8-hour TWA for TCE is 100 ppm. 
7. The best choice is B. EPA has established a drinking water maximum contaminant level 
(MCL) for trichloroethylene of 5 ppb. 
8. The best choice is D. A relatively small amount of absorbed TCE is exhaled unchanged; 
most of an absorbed dose is metabolized in the liver and excreted in the urine as 
trichloroacetic acid and trichloroethanol. 
9. The best choice is A. The cytochrome P450 pathway generates tri- and dichloroacetate 
as metabolites of trichloroethylene, and these are associated with hepatic toxicity and 
carcinogenicity. 
10. The best choice is B. Brain cancer risk has not been reported to be significantly elevated 
in association with TCE exposure. 
11. The best choice is B. Trigeminal abnormalities (abnormal blink reflex and masseter). 
12. The best choice is B. Inhalation or oral exposure to high doses of TCE for a prolonged 
period is likely to induce liver and lung tumors in both animals and humans. 
13. The best choice is C. A temporal relationship between onset of symptoms and work or 
other activity may provide important clues on the cause. If a temporal association 
between symptoms and exposure to certain products is suspected, an attempt should be 
made to identify the specific chemical ingredients involved. 
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14. The best choice is B. Short-term memory impairments gradually clear after exposure to 
TCE ceases. Patients may be mistakenly diagnosed with various forms of dementia, such 
as Alzheimer disease or other CNS disorders, when they in fact suffer from a 
preventable and possibly reversible toxic disorder. The best choice is D. Diarrhea is one 
of the effects from ingestion of TCE.  
15. The best choice is B. If the cause of symptoms is questionable, direct biologic testing, 
such as measuring TCE level in breath, blood, or urine, may be warranted to confirm 
TCE exposure. 
16. The best choice is D. Supportive care directed to adequate ventilation and circulation 
should be provided. Patients should be removed from the contaminated environment as 
soon as possible; begin artificial ventilation, if needed. 
17. The best choice is D. There is no antidote for TCE poisoning. Treatment should focus on 
support of respiratory and cardiovascular functions. 
18. The best choice is D. If exposures are occupational, patients should speak to their 
employer about PPE. Patients should be advised to avoid exposures and conditions that 
might further increase their risk of disease or worsen their existing condition. In 
addition, patients should contact their physician if they develop neurological problems or 
other health changes. 
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